- Report
- August 2023
- 80 Pages
Europe
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 80 Pages
Africa
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 70 Pages
Spain
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 70 Pages
Middle East, Africa
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 80 Pages
Global
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 70 Pages
North America
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 70 Pages
Asia Pacific
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 70 Pages
South Korea
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 110 Pages
Global
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 150 Pages
North America
From €4222EUR$4,750USD£3,684GBP
- Report
- August 2023
- 90 Pages
Global
From €4222EUR$4,750USD£3,684GBP
- Report
- April 2023
- 110 Pages
Global
From €4222EUR$4,750USD£3,684GBP
- Report
- April 2023
- 115 Pages
Global
From €4222EUR$4,750USD£3,684GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3111EUR$3,500USD£2,715GBP
- Report
- April 2024
- 185 Pages
Global
From €3999EUR$4,500USD£3,490GBP
From €3111EUR$3,500USD£2,715GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €3111EUR$3,500USD£2,715GBP
- Report
- December 2024
- 85 Pages
Spain
From €3111EUR$3,500USD£2,715GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more